Global Urticaria Drug Market Research Report 2023

Urticaria Drug Market

Urticaria is commonly known as rubella. It is a localized edema response due to dilation of the skin and mucosal small blood vessels and increased permeability. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of the disease is delayed for several days to several months. More common in clinically.

The global Urticaria Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Urticaria Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Urticaria Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Urticaria Drug include Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech and Xolair, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urticaria Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urticaria Drug.

The Urticaria Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urticaria Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urticaria Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Urticaria Drug Market Report

Core Chapters

1.1 Product Overview and Scope of Urticaria Drug

1.2 Urticaria Drug Segment by Type

1.2.1 Global Urticaria Drug Market Value Comparison by Type (2023-2029)

1.2.2 Acute Urticaria

1.2.3 Chronic Urticaria

1.3 Urticaria Drug Segment by Application

1.3.1 Global Urticaria Drug Market Value by Application: (2023-2029)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Others

1.4 Global Urticaria Drug Market Size Estimates and Forecasts

1.4.1 Global Urticaria Drug Revenue 2018-2029

1.4.2 Global Urticaria Drug Sales 2018-2029

1.4.3 Global Urticaria Drug Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Urticaria Drug Sales Market Share by Manufacturers (2018-2023)

2.2 Global Urticaria Drug Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Urticaria Drug Average Price by Manufacturers (2018-2023)

2.4 Global Urticaria Drug Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Urticaria Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Urticaria Drug, Product Type & Application

2.7 Urticaria Drug Market Competitive Situation and Trends

2.7.1 Urticaria Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Urticaria Drug Players Market Share by Revenue

2.7.3 Global Urticaria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Urticaria Drug Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Urticaria Drug Global Urticaria Drug Sales by Region: 2018-2029

3.2.1 Global Urticaria Drug Sales by Region: 2018-2023

3.2.2 Global Urticaria Drug Sales by Region: 2024-2029

3.3 Global Urticaria Drug Global Urticaria Drug Revenue by Region: 2018-2029

3.3.1 Global Urticaria Drug Revenue by Region: 2018-2023

3.3.2 Global Urticaria Drug Revenue by Region: 2024-2029

3.4 North America Urticaria Drug Market Facts & Figures by Country

3.4.1 North America Urticaria Drug Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Urticaria Drug Sales by Country (2018-2029)

3.4.3 North America Urticaria Drug Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Urticaria Drug Market Facts & Figures by Country

3.5.1 Europe Urticaria Drug Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Urticaria Drug Sales by Country (2018-2029)

3.5.3 Europe Urticaria Drug Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Urticaria Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Urticaria Drug Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Urticaria Drug Sales by Country (2018-2029)

3.6.3 Asia Pacific Urticaria Drug Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Urticaria Drug Market Facts & Figures by Country

3.7.1 Latin America Urticaria Drug Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Urticaria Drug Sales by Country (2018-2029)

3.7.3 Latin America Urticaria Drug Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Urticaria Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Urticaria Drug Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Urticaria Drug Sales by Country (2018-2029)

3.8.3 Middle East and Africa Urticaria Drug Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Urticaria Drug Sales by Type (2018-2029)

4.1.1 Global Urticaria Drug Sales by Type (2018-2023)

4.1.2 Global Urticaria Drug Sales by Type (2024-2029)

4.1.3 Global Urticaria Drug Sales Market Share by Type (2018-2029)

4.2 Global Urticaria Drug Revenue by Type (2018-2029)

4.2.1 Global Urticaria Drug Revenue by Type (2018-2023)

4.2.2 Global Urticaria Drug Revenue by Type (2024-2029)

4.2.3 Global Urticaria Drug Revenue Market Share by Type (2018-2029)

4.3 Global Urticaria Drug Price by Type (2018-2029)

5.1 Global Urticaria Drug Sales by Application (2018-2029)

5.1.1 Global Urticaria Drug Sales by Application (2018-2023)

5.1.2 Global Urticaria Drug Sales by Application (2024-2029)

5.1.3 Global Urticaria Drug Sales Market Share by Application (2018-2029)

5.2 Global Urticaria Drug Revenue by Application (2018-2029)

5.2.1 Global Urticaria Drug Revenue by Application (2018-2023)

5.2.2 Global Urticaria Drug Revenue by Application (2024-2029)

5.2.3 Global Urticaria Drug Revenue Market Share by Application (2018-2029)

5.3 Global Urticaria Drug Price by Application (2018-2029)

6.1 Johnson and Johnson Services

6.1.1 Johnson and Johnson Services Corporation Information

6.1.2 Johnson and Johnson Services Description and Business Overview

6.1.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Johnson and Johnson Services Urticaria Drug Product Portfolio

6.1.5 Johnson and Johnson Services Recent Developments/Updates

6.2 Amneal Pharmaceuticals

6.2.1 Amneal Pharmaceuticals Corporation Information

6.2.2 Amneal Pharmaceuticals Description and Business Overview

6.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio

6.2.5 Amneal Pharmaceuticals Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Urticaria Drug Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Taro Pharmaceutical Industries Novartis AG

6.4.1 Taro Pharmaceutical Industries Novartis AG Corporation Information

6.4.2 Taro Pharmaceutical Industries Novartis AG Description and Business Overview

6.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio

6.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates

6.5 Akorn

6.5.1 Akorn Corporation Information

6.5.2 Akorn Description and Business Overview

6.5.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Akorn Urticaria Drug Product Portfolio

6.5.5 Akorn Recent Developments/Updates

6.6 Teva Pharmaceutical Industries

6.6.1 Teva Pharmaceutical Industries Corporation Information

6.6.2 Teva Pharmaceutical Industries Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio

6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.7 Genentech

6.6.1 Genentech Corporation Information

6.6.2 Genentech Description and Business Overview

6.6.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Genentech Urticaria Drug Product Portfolio

6.7.5 Genentech Recent Developments/Updates

6.8 Xolair

6.8.1 Xolair Corporation Information

6.8.2 Xolair Description and Business Overview

6.8.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Xolair Urticaria Drug Product Portfolio

6.8.5 Xolair Recent Developments/Updates

7.1 Urticaria Drug Industry Chain Analysis

7.2 Urticaria Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Urticaria Drug Production Mode & Process

7.4 Urticaria Drug Sales and Marketing

7.4.1 Urticaria Drug Sales Channels

7.4.2 Urticaria Drug Distributors

7.5 Urticaria Drug Customers

8.1 Urticaria Drug Industry Trends

8.2 Urticaria Drug Market Drivers

8.3 Urticaria Drug Market Challenges

8.4 Urticaria Drug Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Urticaria Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Urticaria Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Urticaria Drug Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Urticaria Drug Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Urticaria Drug Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Urticaria Drug Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Urticaria Drug Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Urticaria Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Urticaria Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Urticaria Drug, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Urticaria Drug, Product Type & Application

    Table 12. Global Key Manufacturers of Urticaria Drug, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Urticaria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urticaria Drug as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Urticaria Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Urticaria Drug Sales by Region (2018-2023) & (K Units)

    Table 18. Global Urticaria Drug Sales Market Share by Region (2018-2023)

    Table 19. Global Urticaria Drug Sales by Region (2024-2029) & (K Units)

    Table 20. Global Urticaria Drug Sales Market Share by Region (2024-2029)

    Table 21. Global Urticaria Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Urticaria Drug Revenue Market Share by Region (2018-2023)

    Table 23. Global Urticaria Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Urticaria Drug Revenue Market Share by Region (2024-2029)

    Table 25. North America Urticaria Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Urticaria Drug Sales by Country (2018-2023) & (K Units)

    Table 27. North America Urticaria Drug Sales by Country (2024-2029) & (K Units)

    Table 28. North America Urticaria Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Urticaria Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Urticaria Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Urticaria Drug Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Urticaria Drug Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Urticaria Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Urticaria Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Urticaria Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Urticaria Drug Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Urticaria Drug Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Urticaria Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Urticaria Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Urticaria Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Urticaria Drug Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Urticaria Drug Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Urticaria Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Urticaria Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Urticaria Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Urticaria Drug Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Urticaria Drug Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Urticaria Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Urticaria Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Urticaria Drug Sales (K Units) by Type (2018-2023)

    Table 51. Global Urticaria Drug Sales (K Units) by Type (2024-2029)

    Table 52. Global Urticaria Drug Sales Market Share by Type (2018-2023)

    Table 53. Global Urticaria Drug Sales Market Share by Type (2024-2029)

    Table 54. Global Urticaria Drug Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Urticaria Drug Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Urticaria Drug Revenue Market Share by Type (2018-2023)

    Table 57. Global Urticaria Drug Revenue Market Share by Type (2024-2029)

    Table 58. Global Urticaria Drug Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Urticaria Drug Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Urticaria Drug Sales (K Units) by Application (2018-2023)

    Table 61. Global Urticaria Drug Sales (K Units) by Application (2024-2029)

    Table 62. Global Urticaria Drug Sales Market Share by Application (2018-2023)

    Table 63. Global Urticaria Drug Sales Market Share by Application (2024-2029)

    Table 64. Global Urticaria Drug Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Urticaria Drug Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Urticaria Drug Revenue Market Share by Application (2018-2023)

    Table 67. Global Urticaria Drug Revenue Market Share by Application (2024-2029)

    Table 68. Global Urticaria Drug Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Urticaria Drug Price (US$/Unit) by Application (2024-2029)

    Table 70. Johnson and Johnson Services Corporation Information

    Table 71. Johnson and Johnson Services Description and Business Overview

    Table 72. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Johnson and Johnson Services Urticaria Drug Product

    Table 74. Johnson and Johnson Services Recent Developments/Updates

    Table 75. Amneal Pharmaceuticals Corporation Information

    Table 76. Amneal Pharmaceuticals Description and Business Overview

    Table 77. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Amneal Pharmaceuticals Urticaria Drug Product

    Table 79. Amneal Pharmaceuticals Recent Developments/Updates

    Table 80. Pfizer Corporation Information

    Table 81. Pfizer Description and Business Overview

    Table 82. Pfizer Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Pfizer Urticaria Drug Product

    Table 84. Pfizer Recent Developments/Updates

    Table 85. Taro Pharmaceutical Industries Novartis AG Corporation Information

    Table 86. Taro Pharmaceutical Industries Novartis AG Description and Business Overview

    Table 87. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product

    Table 89. Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates

    Table 90. Akorn Corporation Information

    Table 91. Akorn Description and Business Overview

    Table 92. Akorn Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Akorn Urticaria Drug Product

    Table 94. Akorn Recent Developments/Updates

    Table 95. Teva Pharmaceutical Industries Corporation Information

    Table 96. Teva Pharmaceutical Industries Description and Business Overview

    Table 97. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Teva Pharmaceutical Industries Urticaria Drug Product

    Table 99. Teva Pharmaceutical Industries Recent Developments/Updates

    Table 100. Genentech Corporation Information

    Table 101. Genentech Description and Business Overview

    Table 102. Genentech Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Genentech Urticaria Drug Product

    Table 104. Genentech Recent Developments/Updates

    Table 105. Xolair Corporation Information

    Table 106. Xolair Description and Business Overview

    Table 107. Xolair Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Xolair Urticaria Drug Product

    Table 109. Xolair Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Urticaria Drug Distributors List

    Table 113. Urticaria Drug Customers List

    Table 114. Urticaria Drug Market Trends

    Table 115. Urticaria Drug Market Drivers

    Table 116. Urticaria Drug Market Challenges

    Table 117. Urticaria Drug Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Urticaria Drug

    Figure 2. Global Urticaria Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Urticaria Drug Market Share by Type in 2022 & 2029

    Figure 4. Acute Urticaria Product Picture

    Figure 5. Chronic Urticaria Product Picture

    Figure 6. Global Urticaria Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Urticaria Drug Market Share by Application in 2022 & 2029

    Figure 8. Hospital Pharmacies

    Figure 9. Retail Pharmacies

    Figure 10. Online Pharmacies

    Figure 11. Others

    Figure 12. Global Urticaria Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Urticaria Drug Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Urticaria Drug Sales (2018-2029) & (K Units)

    Figure 15. Global Urticaria Drug Average Price (US$/Unit) & (2018-2029)

    Figure 16. Urticaria Drug Report Years Considered

    Figure 17. Urticaria Drug Sales Share by Manufacturers in 2022

    Figure 18. Global Urticaria Drug Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Urticaria Drug Players: Market Share by Revenue in 2022

    Figure 20. Urticaria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Urticaria Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Urticaria Drug Sales Market Share by Country (2018-2029)

    Figure 23. North America Urticaria Drug Revenue Market Share by Country (2018-2029)

    Figure 24. United States Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Urticaria Drug Sales Market Share by Country (2018-2029)

    Figure 27. Europe Urticaria Drug Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Urticaria Drug Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Urticaria Drug Revenue Market Share by Region (2018-2029)

    Figure 35. China Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. China Taiwan Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Urticaria Drug Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Urticaria Drug Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Urticaria Drug Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Urticaria Drug Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. UAE Urticaria Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Urticaria Drug by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Urticaria Drug by Type (2018-2029)

    Figure 56. Global Urticaria Drug Price (US$/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Urticaria Drug by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Urticaria Drug by Application (2018-2029)

    Figure 59. Global Urticaria Drug Price (US$/Unit) by Application (2018-2029)

    Figure 60. Urticaria Drug Value Chain

    Figure 61. Urticaria Drug Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed